152 related articles for article (PubMed ID: 3447980)
1. The course of Legionella pneumonia in guinea pigs after inhalation of various quantities of L. pneumophila.
Twisk-Meijssen MJ; Meenhorst PL; van Cronenburg BJ; Mulder JD; Scheffer E; van Furth R
Immunobiology; 1987 Dec; 176(1-2):108-24. PubMed ID: 3447980
[TBL] [Abstract][Full Text] [Related]
2. Legionnaires' pneumonia after intratracheal inoculation of guinea pigs and rats.
Winn WC; Davis GS; Gump DW; Craighead JE; Beaty HN
Lab Invest; 1982 Dec; 47(6):568-78. PubMed ID: 7144138
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia.
Edelstein PH; Shinzato T; Doyle E; Edelstein MA
Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675
[TBL] [Abstract][Full Text] [Related]
4. Aerosol infection of animals with strains of Legionella pneumophila of different virulence: comparison with intraperitoneal and intranasal routes of infection.
Fitzgeorge RB; Baskerville A; Broster M; Hambleton P; Dennis PJ
J Hyg (Lond); 1983 Feb; 90(1):81-9. PubMed ID: 6401778
[TBL] [Abstract][Full Text] [Related]
5. Sequential changes of Legionella antigens and bacterial load in the lungs and urines of a mouse model of pneumonia.
Chen Y; Tateda K; Fujita K; Ishii T; Ishii Y; Kimura S; Saga T; Annaka T; Yamada S; Zhao L; Li S; Azuma A; Gemma A; Kudoh S; Yamaguchi K
Diagn Microbiol Infect Dis; 2010 Mar; 66(3):253-60. PubMed ID: 20159373
[TBL] [Abstract][Full Text] [Related]
6. Guinea pigs sublethally infected with aerosolized Legionella pneumophila develop humoral and cell-mediated immune responses and are protected against lethal aerosol challenge. A model for studying host defense against lung infections caused by intracellular pathogens.
Breiman RF; Horwitz MA
J Exp Med; 1987 Mar; 165(3):799-811. PubMed ID: 3819647
[TBL] [Abstract][Full Text] [Related]
7. A comparison of virulence of two strains of Legionella pneumophila based on experimental aerosol infection of guinea-pigs.
Jepras RI; Fitzgeorge RB; Baskerville A
J Hyg (Lond); 1985 Aug; 95(1):29-38. PubMed ID: 4020112
[TBL] [Abstract][Full Text] [Related]
8. Histopathology of experimental Legionnaires' disease in guinea pigs, rhesus monkeys and marmosets.
Baskerville A; Fitzgeorge RB; Broster M; Hambleton P
J Pathol; 1983 Mar; 139(3):349-62. PubMed ID: 6834178
[TBL] [Abstract][Full Text] [Related]
9. Non-specific protection against pulmonary Legionella pneumophila infection in guinea-pigs immunized and challenged with mycobacteria.
Gibson DH; Baskerville A; Ashworth LA; Fitzgeorge RB
Br J Exp Pathol; 1985 Jun; 66(3):333-44. PubMed ID: 3924087
[TBL] [Abstract][Full Text] [Related]
10. Legionnaires' pneumonia after aerosol exposure in guinea pigs and rats.
Davis GS; Winn WC; Gump DW; Craighead JE; Beaty HN
Am Rev Respir Dis; 1982 Dec; 126(6):1050-7. PubMed ID: 6983846
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease.
Blander SJ; Horwitz MA
J Exp Med; 1989 Mar; 169(3):691-705. PubMed ID: 2926324
[TBL] [Abstract][Full Text] [Related]
12. [Legionnaires' disease (etiology, epidemiology, morphology and pathogenesis of "legionnaires" disease)].
Shtern RD; Ageev AK
Arkh Patol; 1982; 44(11):78-85. PubMed ID: 6760836
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-activating T-cell factor(s) produced in an early phase of Legionella pneumophila infection in guinea pigs.
Nikaido Y; Yoshida S; Goto Y; Mizuguchi Y; Kuroiwa A
Infect Immun; 1989 Nov; 57(11):3458-65. PubMed ID: 2807531
[TBL] [Abstract][Full Text] [Related]
14. [Histopathological characteristics of Legionella pneumophila infection in man and guinea pigs].
Kokorin IN; Eruslanov BV; Tartakovskiĭ IS; Petrosov VV; Prozorovskiĭ SV
Arkh Patol; 1981; 43(4):18-25. PubMed ID: 7236041
[TBL] [Abstract][Full Text] [Related]
15. Separation of Legionella pneumophila proteases and purification of a protease which produces lesions like those of Legionnaires' disease in guinea pig lung.
Conlan JW; Baskerville A; Ashworth LA
J Gen Microbiol; 1986 Jun; 132(6):1565-74. PubMed ID: 3543209
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with the major secretory protein of Legionella induces humoral and cell-mediated immune responses and protective immunity across different serogroups of Legionella pneumophila and different species of Legionella.
Blander SJ; Horwitz MA
J Immunol; 1991 Jul; 147(1):285-91. PubMed ID: 1711078
[TBL] [Abstract][Full Text] [Related]
17. A quantitative microbial risk assessment model for Legionnaires' disease: animal model selection and dose-response modeling.
Armstrong TW; Haas CN
Risk Anal; 2007 Dec; 27(6):1581-96. PubMed ID: 18093054
[TBL] [Abstract][Full Text] [Related]
18. Long-term followup of two patients with pulmonary cavitation caused by Legionella pneumophila.
Edelstein PH; Meyer RD; Finegold SM
Am Rev Respir Dis; 1981 Jul; 124(1):90-3. PubMed ID: 7020508
[TBL] [Abstract][Full Text] [Related]
19. Changes in iron and transferrin levels and body temperature in experimental airborne legionellosis.
Muller D; Edwards ML; Smith DW
J Infect Dis; 1983 Feb; 147(2):302-7. PubMed ID: 6827146
[TBL] [Abstract][Full Text] [Related]
20. Myeloid differentiation primary response gene (88)- and toll-like receptor 2-deficient mice are susceptible to infection with aerosolized Legionella pneumophila.
Hawn TR; Smith KD; Aderem A; Skerrett SJ
J Infect Dis; 2006 Jun; 193(12):1693-702. PubMed ID: 16703513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
